105 related articles for article (PubMed ID: 7947608)
21. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1 inhibits the synthesis of von Willebrand factor in endothelial cells, which results in a decreased reactivity of their matrix toward platelets.
de Groot PG; Verweij CL; Nawroth PP; de Boer HC; Stern DM; Sixma JJ
Arteriosclerosis; 1987; 7(6):605-11. PubMed ID: 3318780
[TBL] [Abstract][Full Text] [Related]
23. [Studies on tissue factor generation of cultured human vascular endothelial cells].
Uchiyama T; Andoh K; Kobayashi N; Maekawa T
Nihon Ketsueki Gakkai Zasshi; 1988 Nov; 51(7):1209-14. PubMed ID: 3223218
[No Abstract] [Full Text] [Related]
24. Differential effects of radiocontrast agents on human umbilical vein endothelial cells: cytotoxicity and modulators of thrombogenicity.
Fauser C; Ullisch EV; Kübler W; Haller C
Eur J Med Res; 2001 Nov; 6(11):465-72. PubMed ID: 11726305
[TBL] [Abstract][Full Text] [Related]
25. Comparison of human umbilical vein and adult saphenous vein endothelial cells: implications for newborn hemostasis and for laboratory models of endothelial cell function.
Grabowski EF; Carter CA; Tsukurov O; Conroy N; Hsu CY; Abbott WM; Ingelfinger JR; Orkin RW
J Pediatr Hematol Oncol; 2000; 22(3):266-8. PubMed ID: 10864062
[No Abstract] [Full Text] [Related]
26. Comparison of secretion and subcellular localization of von Willebrand protein with that of thrombospondin and fibronectin in cultured human vascular endothelial cells.
Reinders JH; de Groot PG; Dawes J; Hunter NR; van Heugten HA; Zandbergen J; Gonsalves MD; van Mourik JA
Biochim Biophys Acta; 1985 Mar; 844(3):306-13. PubMed ID: 3882157
[TBL] [Abstract][Full Text] [Related]
27. Type VII collagen gene expression in human umbilical tissue and cells.
Ryynänen J; Tan EM; Hoffren J; Woodley DT; Sollberg S
Lab Invest; 1993 Sep; 69(3):300-4. PubMed ID: 7690866
[TBL] [Abstract][Full Text] [Related]
28. Stimulation of tissue factor expression in human microvascular and macrovascular endothelial cells by cultured vascular smooth muscle cells in vitro.
Zhang JC; Ruan Q; Paucz L; Fabry A; Binder BR; Wojta J
J Vasc Res; 1999; 36(2):126-32. PubMed ID: 10213908
[TBL] [Abstract][Full Text] [Related]
29. Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro.
Wojta J; Holzer M; Hufnagl P; Christ G; Hoover RL; Binder BR
Am J Pathol; 1991 Oct; 139(4):911-9. PubMed ID: 1928306
[TBL] [Abstract][Full Text] [Related]
30. Toxicity of sitosterol to human umbilical vein endothelial cells in vitro.
Boberg KM; Pettersen KS; Prydz H
Scand J Clin Lab Invest; 1991 Oct; 51(6):509-16. PubMed ID: 1767244
[TBL] [Abstract][Full Text] [Related]
31. Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells.
Schleef RR; Loskutoff DJ; Podor TJ
J Cell Biol; 1991 Jun; 113(6):1413-23. PubMed ID: 2045419
[TBL] [Abstract][Full Text] [Related]
32. Identification and partial purification of a novel tumor-derived protein that induces tissue factor on cultured human endothelial cells.
Noguchi M; Sakai T; Kisiel W
Biochem Biophys Res Commun; 1989 Apr; 160(1):222-7. PubMed ID: 2653316
[TBL] [Abstract][Full Text] [Related]
33. In-vitro effect of oncostatin M on the release by endothelial cells of von Willebrand factor, tissue-type plasminogen activator and plasminogen activator inhibitor-1.
Pourtau J; Soria C; Paysant J; Vannier JP; Vasse M
Blood Coagul Fibrinolysis; 1998 Oct; 9(7):609-15. PubMed ID: 9863709
[TBL] [Abstract][Full Text] [Related]
34. Influence of intercellular junctions on endothelin secretion of human umbilical vein endothelial cells in vitro.
Kiessling F; Becker D; Ullisch EV; Kübler W; Haller C
Basic Res Cardiol; 2000 Aug; 95(4):299-307. PubMed ID: 11005585
[TBL] [Abstract][Full Text] [Related]
35. Fibroblast growth factor and heparin protect endothelial cells from the effects of interleukin 1.
Minter AJ; Keoshkerian E; Chesterman CN; Dawes J
J Cell Physiol; 1996 May; 167(2):229-37. PubMed ID: 8613463
[TBL] [Abstract][Full Text] [Related]
36. Studies of the factor Xa-dependent inhibitor of factor VIIa/tissue factor (extrinsic pathway inhibitor) from cell supernates of cultured human umbilical vein endothelial cells.
Warn-Cramer BJ; Almus FE; Rapaport SI
Thromb Haemost; 1989 Feb; 61(1):101-5. PubMed ID: 2665164
[TBL] [Abstract][Full Text] [Related]
37. Basic fibroblast growth factor suppresses tissue plasminogen activator release from cultured human umbilical vein endothelial cells but enhances that from cultured human aortic endothelial cells.
Yamamoto C; Kaji T; Furuya M; Sakamoto M; Kozuka H; Koizumi F
Thromb Res; 1994 Feb; 73(3-4):255-63. PubMed ID: 8191418
[TBL] [Abstract][Full Text] [Related]
38. Increased secretion of urokinase-type plasminogen activator by human lung microvascular endothelial cells.
Takahashi K; Uwabe Y; Sawasaki Y; Kiguchi T; Nakamura H; Kashiwabara K; Yagyu H; Matsuoka T
Am J Physiol; 1998 Jul; 275(1):L47-54. PubMed ID: 9688934
[TBL] [Abstract][Full Text] [Related]
39. Interferon-alpha 2 counteracts interleukin-1 alpha-stimulated expression of urokinase-type plasminogen activator in human foreskin microvascular endothelial cells in vitro.
Wojta J; Zoellner H; Gallicchio M; Filonzi EL; Hamilton JA; McGrath K
Lymphokine Cytokine Res; 1994 Apr; 13(2):133-8. PubMed ID: 8061114
[TBL] [Abstract][Full Text] [Related]
40. Induction of interleukin-1 and subsequent tissue factor expression by anti-proteinase 3 antibodies in human umbilical vein endothelial cells.
de Bandt M; Ollivier V; Meyer O; Babin-Chevaye C; Khechaï F; de Prost D; Hakim J; Pasquier C
Arthritis Rheum; 1997 Nov; 40(11):2030-8. PubMed ID: 9365093
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
